secwatch.observer — SEC 8-K summary
======================================

Issuer:     DEXCOM INC (DXCM)
CIK:        0001093557
Form:       8-K
Filed at:   2023-10-26T23:59:59+00:00
Accession:  0001093557-23-000219
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dexcom Q3 revenue up 27% to $975M; raises FY2023 guidance, announces $500M buyback
--------------------------------------------------------------------------------

- GAAP revenue $975.0M (+27% YoY); U.S. +24%, international +33%.
- GAAP operating income $205.5M (21.1% margin); non-GAAP operating income $238.9M.
- Non-GAAP diluted EPS $0.50 vs $0.28 YoY; GAAP EPS $0.29.
- FY2023 revenue guidance raised to $3.575-3.600B (23-24% growth); non-GAAP operating margin ~19%.
- Board authorized $500M share repurchase program; cash and securities $3.24B.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1093557/000109355723000219/0001093557-23-000219-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1093557/000109355723000219/dxcm-20231026.htm
  HTML page:      https://secwatch.observer/filing/0001093557-23-000219

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer